Illumina Inc. sued rival DNA sequencing company BillionToOne Inc. for allegedly infringing three of its patents related to noninvasive prenatal testing methods.
Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global ...
StockStory.org on MSN
ILMN Q1 deep dive: Clinical sequencing fuels growth as NovaSeq X demand surges
Genomics company Illumina (NASDAQ:ILMN) reported Q1 CY2026 results , with sales up 4.8% year on year to $1.09 billion. The ...
Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...
Hosted on MSN
Mastering whole genome sequencing coverage planning
Whole genome sequencing (WGS) delivers deep insights into genetics, but its reliability depends on aligning coverage depth and uniformity with the study’s goals. Current research and practical guides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results